Status:

COMPLETED

Histamine Responsiveness in McCune-Albright Syndrome

Lead Sponsor:

Children's Mercy Hospital Kansas City

Collaborating Sponsors:

KBR

Conditions:

McCune-Albright Syndrome

Eligibility:

All Genders

Up to 39 years

Brief Summary

McCune-Albright syndrome (MAS) is a syndrome caused by a genetic mutation that causes a specific protein in the body called a G protein to be constantly active. Children with McCune-Albright syndrome ...

Detailed Description

Objectives of this study are to determine if: 1. Patients with McCune-Albright syndrome differ from unaffected controls in wheal and flare response to histamine and codeine. 2. Affected skin will dif...

Eligibility Criteria

Inclusion

  • Children with MAS ranging from toddlers to young adults.
  • Diagnosis of MAS will be made on a clinical basis. Blood testing is not helpful in this condition, as bone marrow progenitor cells with the Gαs mutation display a survival disadvantage. All patients are mixed chimeras, as this mutation is lethal if it occurs in germline cells.
  • Patients who exhibit two or more of the following clinical findings fit the diagnosis of MAS:
  • GnRH independent precocious puberty
  • Polyostotic fibrous dysplasia
  • Café-au-lait spots with coast of Maine borders and respect for the midline.
  • Non-autoimmune hyperthyroidism.
  • Ten controls will also be recruited from family members of patients with MAS with no known allergies. An additional control group of ten unrelated subjects, also with no known allergies, will be recruited from the Endocrine Clinic for comparison.

Exclusion

  • Any MAS patient or control who has not, or cannot, discontinue(d) any home regimens of antihistamines or glucocorticoids (including inhaled steroids) at least seven days prior to skin testing.
  • Any MAS patient or control on tricyclic antidepressants within two weeks prior to skin testing.

Key Trial Info

Start Date :

August 1 2004

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2007

Estimated Enrollment :

22 Patients enrolled

Trial Details

Trial ID

NCT00318097

Start Date

August 1 2004

End Date

August 1 2007

Last Update

February 6 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Children's Mercy Hospitals and Clinics

Kansas City, Missouri, United States, 64108

Histamine Responsiveness in McCune-Albright Syndrome | DecenTrialz